| Profitability | 61/100 |
| Growth | 60/100 |
| Momentum | 88/100 |
| Quality | 79/100 |
| Earnings Quality | 74/100 |
| Balance Sheet | 56/100 |
| Value | 45/100 |
| Risk (safety) | 80/100 |
| Overall | 69.2/100 |
| Symbol | IS Score |
|---|---|
| AVTR | 20 |
| RGEN | 64 |
| BAX | 32 |
| SOLV | 37 |
| ATR | 55 |
| HOLX | 56 |
| COO | 69 |
Both readings sit above the midpoint — business quality at 69 and price structure at 59 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.
| Trigger | Where it stands now | What it would mean |
|---|---|---|
| IS Score reaches 75 and holds two consecutive quarters | now 69.2 | would move us up one band |
| IS Score stops falling - one quarter higher than the prior | last four: 56 → 58 → 51 → 69 | the direction matters more than the level |
| Technical vote share back above 50% | now 64% | price structure no longer broken |
| Institutional holder count rises two quarters running | peak 674 → now 673 | fewer institutions willing to hold is our clearest warning |
This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.
| Quarter | Holders | 13F shares | Value | Reported own% | Guard |
|---|---|---|---|---|---|
| 2026 Q2 | 673 | 211.1M | $14.2B | 109.2% | ex-outlier 101.4% |
| 2026 Q1 | 671 | 204.3M | $13.5B | 105.6% | ex-outlier 97.0% |
| 2025 Q4 | 665 | 202.5M | $15.2B | 104.7% | |
| 2025 Q3 | 626 | 203.9M | $12.9B | 105.5% | |
| 2025 Q2 | 623 | 200.9M | $13.1B | 103.9% | |
| 2025 Q1 | 637 | 198.5M | $15.6B | 102.6% | |
| 2024 Q4 | 674 | 195.6M | $16.9B | 101.1% | |
| 2024 Q3 | 651 | 191.0M | $19.9B | 98.8% | |
| 2024 Q2 | 619 | 192.5M | $16.0B | 99.5% | |
| 2024 Q1 | 575 | 187.3M | $17.9B | 96.8% | |
| 2023 Q4 | 6 | 1.5M | $0.1B | 0.8% | |
| 2023 Q3 | 1 | 0.0M | $0.0B | 0.0% |
Why 2026-06 reads 109.18%. Institutions cannot hold more of a company than exists. The reported 211.1M shares exceed the 193.4M outstanding, and a single filer accounts for the excess: BlackRock, Inc. reports 15,029,453 shares against 16,618,129 the prior quarter, a 1x jump, which alone would be 7.8% of the company. Excluding that filing, ownership is 101.4%. We publish both figures. 13F filings are due 45 days after quarter end and amendments keep arriving after that, so the newest quarter is provisional by construction - this is what an unsettled quarter looks like.
Why 2026-03 reads 105.62%. Institutions cannot hold more of a company than exists. The reported 204.3M shares exceed the 193.4M outstanding, and a single filer accounts for the excess: BlackRock, Inc. reports 16,618,129 shares against 16,487,063 the prior quarter, a 1x jump, which alone would be 8.6% of the company. Excluding that filing, ownership is 97.0%. We publish both figures. 13F filings are due 45 days after quarter end and amendments keep arriving after that, so the newest quarter is provisional by construction - this is what an unsettled quarter looks like.
| Insider | Role | Date | Type | Shares | Value | Post-Txn Owned |
|---|---|---|---|---|---|---|
| Kurzius Lawrence Erik | director | 2026-09-16 | BUY | 10,000 | $0.55M | 31,099 |
| Rosebrough Walter M Jr | director | 2026-09-14 | BUY | 3,000 | $0.16M | 20,000 |
| Kurzius Lawrence Erik | director | 2026-09-14 | BUY | 10,000 | $0.54M | 21,099 |
| Rosebrough Walter M Jr | director | 2026-09-11 | BUY | 7,000 | $0.38M | 17,000 |
| Keel Paul A | director | 2026-09-11 | BUY | 4,701 | $0.25M | 4,701 |
| Keel Paul A | director | 2026-07-01 | A-Award | 2,814 | — | 2,814 |
| Rosebrough Walter M Jr | director | 2026-04-01 | EXERCISE | 832 | — | 832 |
| Rosebrough Walter M Jr | director | 2026-04-01 | EXERCISE | 832 | — | 0 |
| 6-mo decomposition (Form 4) | Txns | Shares | Value | Signal weight |
|---|---|---|---|---|
| P — Open-market purchases | 5 | 34,701 | $1.9M | Counted |
| M — Exercises (paired A/D) | 8 | 24,146 | — | None — mechanics |
| Filed | Filer | Shares registered | Est. proceeds |
|---|---|---|---|
| 2024-09-19 | Albert G. White Iii | 114,992 | $12.7M |
| 2024-09-10 | Agostino Ricupati | 1,601 | $0.2M |
| 2024-09-05 | Brian G. Andrews | 24,788 | $2.6M |
| 2024-09-04 | Daniel Mcbride | 114,992 | $12.1M |
| Trailing 12 mo | 0 filings | — | $0M |
| Filed | Form | Reporting person | % of class | Shares |
|---|---|---|---|---|
| 2026-05-14 | SCHEDULE 13G/A | Capital World Investors | 4.00% | 7.8M sh |
| 2026-04-29 | SCHEDULE 13G | Vanguard Capital Management | 7.51% | 14.7M sh |
| 2026-03-26 | SCHEDULE 13G/A | The Vanguard Group | — | exit/reporting change |
| 2025-11-13 | SCHEDULE 13G | Capital World Investors | 5.50% | 11.0M sh |
| Member | Chamber | Trade | Size band | Traded | Disclosed |
|---|---|---|---|---|---|
| Ro Khanna | House | BUY | $1,001 - $15,000 | 2026-09-17 | 2026-10-09 |
| Ro Khanna | House | BUY | $1,001 - $15,000 | 2026-09-17 | 2026-10-09 |
| Ro Khanna | House | BUY | $1,001 - $15,000 | 2026-09-16 | 2026-10-09 |
| Alan Armstrong | Senate | BUY | $1,001 - $15,000 | 2026-03-27 | 2026-07-21 |
| Manager | Shares | Value |
|---|---|---|
| Border To Coast Pensions Partnersh | 417,578 | $24M |
| Assenagon Asset Management S.A. | 123,117 | $7M |
| Thompson Investment Management, In | 69,587 | $4M |
| Mn Services Vermogensbeheer B.V. | 59,711 | $3M |
| Czech National Bank | 56,037 | $3M |
| Davenport & Co Llc | 45,902 | $3M |
| Fund | Weight | Position |
|---|---|---|
| VITSX | 0.0% | $351M |
| VTSAX | 0.0% | $351M |
| VSMPX | 0.0% | $351M |
| VTI | 0.0% | $351M |
| VFFSX | 0.0% | $290M |
| VFINX | 0.0% | $290M |
| ATS Venue (4-wk) | Shares | Avg trade |
|---|---|---|
| Incr Intelligent Cross Llc | 1.4M | 39 sh |
| Ubsa Ubs Ats | 1.1M | 47 sh |
| Mstx Ms Trajectory Cross (Ats-1) | 0.8M | 34 sh |
| Sgmt Sigma X2 | 0.7M | 34 sh |
| Ebxl Level Ats | 0.6M | 18 sh |
| Mlix Instinct X | 0.6M | 60 sh |
| Region | Revenue | Share |
|---|---|---|
| UNITED STATES | $2.7B | 46% |
| Europe | $2.4B | 40% |
| Rest Of World, Excluding United States And Europe | $785M | 13% |
Moat score 52/100 — Weak; primary source Efficient Scale.
| Officer | Title |
|---|---|
| Albert G. White | President, Chief Executive Officer & Non-Independent Director |
| Daniel G. McBride | Executive VP, COO General Counsel & Secretary |
| Brian G. Andrews | Executive VP, CFO & Principal Accounting Officer |
| Holly R. Sheffield | President of CooperSurgical, Inc. |
| Period | EPS est. | EPS actual | EPS surprise | Rev est. ($M) | Rev actual ($M) | Rev surprise |
|---|
| YoY growth | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | +20.2% | +13.2% | +8.6% | +8.4% | +5.1% |
| Gross profit | +27.4% | +9.4% | +10.2% | +10.1% | -4.3% |
| Operating income | +62.2% | +0.4% | +5.0% | +32.4% | -3.2% |
| Net income | +1135.2% | -86.9% | -23.7% | +33.3% | -4.4% |
| $B · FY ends | FY21 | FY22 | FY23 | FY24 | FY25 | Trend |
|---|---|---|---|---|---|---|
| Revenue | 2.9 | 3.3 | 3.6 | 3.9 | 4.1 | |
| Cost of revenue | 1.0 | 1.2 | 1.2 | 1.3 | 1.6 | |
| Gross profit | 2.0 | 2.1 | 2.4 | 2.6 | 2.5 | |
| R&D expense | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | |
| SG&A expense | 1.2 | 1.3 | 1.5 | 1.5 | 1.6 | |
| Operating income | 0.5 | 0.5 | 0.5 | 0.7 | 0.7 | |
| EBITDA | 0.8 | 0.9 | 0.9 | 1.1 | 1.1 | |
| D&A | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | |
| Pretax income | 0.5 | 0.5 | 0.4 | 0.6 | 0.6 | |
| Income tax | -2.5 | 0.1 | 0.1 | 0.2 | 0.2 | |
| Net income | 2.9 | 0.4 | 0.3 | 0.4 | 0.4 | |
| Diluted EPS ($) | 59.07 | 1.94 | 1.48 | 1.96 | 1.87 | |
| Diluted shares (M) | 50 | 199 | 199 | 200 | 200 |
| $B | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Cash & equivalents | 0.1 | 0.1 | 0.1 | 0.1 | |
| ST investments | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables (net) | 0.6 | 0.6 | 0.7 | 0.8 | |
| Total current assets | 1.5 | 1.7 | 2.0 | 2.1 | |
| PP&E (net) | 1.4 | 1.6 | 1.9 | 2.1 | |
| Goodwill + intangibles | 5.5 | 5.3 | 5.6 | 5.4 | |
| Total assets | 11.5 | 11.7 | 12.3 | 12.4 | |
| Accounts payable | 0.2 | 0.3 | 0.3 | 0.3 | |
| Short-term debt | 0.4 | 0.0 | 0.0 | 0.1 | |
| Deferred revenue | 0.1 | 0.1 | 0.1 | 0.1 | |
| Total current liabilities | 1.3 | 1.0 | 1.0 | 1.1 | |
| Long-term debt | 2.3 | 2.5 | 2.5 | 2.5 | |
| Total liabilities | 4.3 | 4.1 | 4.2 | 4.2 | |
| Shareholders' equity | 7.2 | 7.6 | 8.1 | 8.2 |
| $B | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Net income | 0.4 | 0.3 | 0.4 | 0.4 | |
| D&A | 0.3 | 0.4 | 0.4 | 0.4 | |
| Stock-based compensation | 0.1 | 0.1 | 0.0 | 0.0 | |
| Working capital change | (0.2) | (0.2) | (0.3) | (0.3) | |
| Operating cash flow | 0.7 | 0.6 | 0.7 | 0.8 | |
| Capital expenditures | (0.2) | (0.4) | (0.4) | (0.4) | |
| Investing cash flow | (1.8) | (0.4) | (0.8) | (0.4) | |
| Buybacks | (0.1) | (0.0) | 0.0 | (0.3) | |
| Dividends paid | (0.0) | (0.0) | 0.0 | 0.0 | |
| Debt issuance / (repay) | 1.3 | (0.2) | 0.0 | (0.1) | |
| Financing cash flow | 1.2 | (0.2) | 0.0 | (0.4) | |
| Free cash flow | 0.5 | 0.2 | 0.3 | 0.4 |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| PROFITABILITY | |||||||
| ROE | 54.7% | 5.5% | 4.0% | 5.0% | 4.6% | 7% | |
| ROA | 36.0% | 3.7% | 2.5% | 3.3% | 3.0% | 4.5% | |
| ROIC | 36.4% | 4.2% | 3.8% | 4.5% | 4.1% | 4.8% | |
| Gross margin | 66.9% | 64.7% | 65.6% | 66.6% | 60.7% | 63.6% | |
| Operating margin | 17.3% | 15.3% | 14.8% | 18.1% | 16.7% | 12.9% | |
| Net margin | 100.8% | 11.7% | 8.2% | 10.1% | 9.2% | 13.5% | |
| EBITDA margin | 28.2% | 26.6% | 24.7% | 27.5% | 25.7% | 21.5% | |
| FCF margin | 17.9% | 13.6% | 6.0% | 7.4% | 10.6% | — | |
| VALUATION | |||||||
| P/E | 1.76 | 35.11 | 52.88 | 53.66 | 36.94 | 19.8 | |
| P/B | 0.75 | 1.89 | 2.06 | 2.60 | 1.68 | 1.3 | |
| P/S | 1.78 | 4.10 | 4.33 | 5.40 | 3.38 | 2.60 | |
| P/FCF | 9.91 | 30.09 | 72.36 | 73.07 | 31.93 | 16.3 | |
| EV/EBITDA | 7.99 | 18.41 | 20.32 | 21.95 | 16.21 | 14.7 | |
| EV/Revenue | 2.25 | 4.89 | 5.01 | 6.04 | 4.04 | 3.2 | |
| Earnings yield | 56.7% | 2.8% | 1.9% | 1.9% | 2.7% | 5.09% | |
| FCF yield | 10.1% | 3.3% | 1.4% | 1.4% | 3.1% | 6.15% | |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| LEVERAGE & SOLVENCY | |||||||
| Current ratio | 2.00 | 1.20 | 1.76 | 1.91 | 1.89 | 1.22 | |
| Quick ratio | 1.20 | 0.71 | 1.00 | 1.12 | 1.13 | 0.73 | |
| Debt / equity | 0.21 | 0.39 | 0.34 | 0.32 | 0.34 | 0.31 | |
| Debt / assets | 15.4% | 24.0% | 22.0% | 21.0% | 22.5% | 20.1% | |
| Net debt / EBITDA | 1.68 | 2.99 | 2.76 | 2.31 | 2.62 | 2.62 | |
| Interest coverage | 22.28 | 9.29 | 4.92 | 6.09 | 5.89 | — | |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| EFFICIENCY | |||||||
| Asset turnover | 0.36 | 0.31 | 0.31 | 0.32 | 0.33 | 0.33 | |
| Receivables turnover | 6.15 | 6.17 | 6.16 | 5.87 | 5.29 | 5.4 | |
| DSO (days) | 59 | 59 | 59 | 62 | 69 | 68 | |
| DPO (days) | 64 | 64 | 75 | 73 | 70 | 60 | |
| Cash conversion cycle | 214 | 185 | 185 | 205 | 205 | 224 | |
| GROWTH (YoY) | |||||||
| Revenue growth | 20.2% | 13.2% | 8.6% | 8.4% | 5.1% | — | |
| Net income growth | 1135.2% | -86.9% | -23.8% | 33.3% | -4.4% | — | |
| EPS growth | 1127.8% | -96.7% | -24.2% | 32.4% | -3.0% | — | |
| FCF growth | 197.5% | -14.1% | -52.3% | 34.0% | 50.5% | — | |
| PER SHARE ($) | |||||||
| EPS (diluted, TTM) | 59.01 | 1.95 | 1.47 | 1.95 | 1.89 | 2.95 | |
| Book value / share | 139.11 | 36.16 | 37.83 | 40.20 | 41.59 | 43.06 | |
| Revenue / share | 58.57 | 16.68 | 18.00 | 19.37 | 20.66 | 21.91 | |
| FCF / share | 10.51 | 2.27 | 1.08 | 1.43 | 2.19 | 3.51 | |
| Cash / share | 1.92 | 0.70 | 0.61 | 0.54 | 0.56 | 0.80 | |
| SHAREHOLDER RETURN & SCORES | |||||||
| Buyback yield | 0.5% | 0.7% | 0.1% | 0.0% | 2.1% | 0.40% | |
| Altman Z-Score | 2.65 | 3.15 | 3.63 | 4.40 | 3.46 | 2.9 | |
| Piotroski F-Score | 6 | 4 | 7 | 8 | 5 | 7/9 | |
| Beneish M-Score | -1.10 | -2.44 | -2.55 | -2.44 | -2.42 | -2.62 | |
| Model | Score | Zone | Note |
|---|---|---|---|
| Piotroski F-Score | 7 / 9 | Strong | |
| Altman Z-Score | 2.9 | Grey zone | Grey |
| Income quality | -22.76 | Accrual-heavy | OCF ÷ net income |
| Beneish M-Score | -2.62 | Non-manipulator | vs −2.22 threshold |
| DuPont Decomposition (TTM) | Value |
|---|---|
| Tax burden | 1.23 |
| Interest burden | 0.88 |
| Operating margin | 12.4% |
| Asset turnover | 0.34× |
| Financial leverage | 1.50× |
| = ROE | 7% |
| Growth Quality (live) | Value |
|---|---|
| Revenue stability | 0.99 |
| Earnings stability | 0.37 |
| Earnings persistence | 0.84 |
| Revenue CAGR 3y | 6.4% |
| EPS CAGR 3y | 28.8% |
| FCF CAGR 3y | 45.2% |
| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | Piotroski | 1-yr ret |
|---|---|---|---|---|---|---|---|
| AVTR | $11.1B | -19.6 | -10% | 2.3% | -1.6% | 6/9 | +12.7% |
| RGEN | $11.1B | 237.1 | 2% | 2.5% | +16.5% | 8/9 | +13.5% |
| BAX | $13.1B | -12.4 | -16% | 4.3% | +5.4% | 3/9 | +10.3% |
| SOLV | $14.6B | 10.4 | 34% | 4.2% | -0.9% | 7/9 | +20.1% |
| ATR | $7.9B | 22.2 | 14% | 8.5% | +8.9% | 6/9 | — |
| HOLX | $17.0B | 30.3 | 11% | 17.1% | +2.2% | 6/9 | — |
| BLCO | $5.9B | -34.5 | -3% | -1.0% | +8.8% | 5/9 | — |
| TFX | $5.5B | -5.6 | -29% | 17.9% | -14.5% | 5/9 | — |
| Consensus estimates | Revenue mean | High / Low | EPS mean | High / Low | # EPS est. |
|---|---|---|---|---|---|
| FY2026 | $4.24B | $4.25B / $4.19B | $4.54 | $4.55 / $4.53 | 11 |
| FY2027 | $4.41B | $4.45B / $4.36B | $4.70 | $4.89 / $4.56 | 11 |
| FY2028 | $4.62B | $4.71B / $4.53B | $5.11 | $5.75 / $4.40 | 9 |
| Window | Avg Target | vs. Price | # Targets |
|---|---|---|---|
| Last Month | $60.00 | +3.6% | 1 |
| Last Quarter | $65.63 | +13.3% | 8 |
| Last Year | $79.48 | +37.2% | 23 |
| All Time | $124.94 | +115.6% | 42 |
| Moving Average | Value | Distance | % Distance | Signal |
|---|---|---|---|---|
| SMA 20 | $55.86 | +2.08 | +3.72% | Above |
| SMA 50 | $63.55 | -5.61 | -8.83% | Below |
| SMA 200 | $70.04 | -12.10 | -17.28% | Below |
| EMA 9 | $56.14 | +1.80 | +3.21% | Above |
| EMA 21 | $56.98 | +0.96 | +1.68% | Above |
| EMA 50 | $60.97 | -3.03 | -4.97% | Below |
| EMA 200 | $68.21 | -10.27 | -15.06% | Below |
| Level | Value | Level | Value |
|---|---|---|---|
| Pivot / R1 / R2 | $56.78 / $58.09 / $58.79 | S1 / S2 | $56.08 / $54.77 |
| Bollinger (20,2) | $53.61 – $58.11 | Squeeze | Off |
| 52-wk range | $51.01 – $89.83 | Off 52-wk high | -35.5% |
| ATR (14) | $1.66 (2.9%) | Historical vol | 28.0% |
| Computed from live weekly prices | COO | S&P 500 |
|---|---|---|
| Weekly volatility (σ, 1y) | 5.20% | 1.83% |
| Best / worst week (1y) | +11.0% / -22.3% | — |
| Max drawdown (5y, monthly) | -48.7% | — |
| 1-week VaR (95%) | -9.2% | — |
| Beta (5y) | 0.82 | 1.00 |
| Reading | COO | Medical - Instruments & Supplies n=284 | Healthcare n=5,272 | All US symbols n=70,435 |
|---|---|---|---|---|
| Overall | -28.8 | -10.3 | -24.0 | -20.5 |
| Trend | -47.0 | +0.7 | -25.6 | -21.3 |
| Momentum | +18.7 | -1.1 | -28.5 | -15.8 |
| Volume | -36.7 | +17.1 | -25.0 | -3.8 |
| Executive | Total comp | Structure |
|---|---|---|
| Albert G. White III President & Chief Execut | $16.1M | 51% equity+incentive |
| Daniel G. McBride Executive Vice President, | $4.8M | 82% equity+incentive |
| Brian G. Andrews Executive Vice President, C | $4.3M | 47% equity+incentive |
| Holly R. Sheffield President, CooperSurgical | $3.7M | 80% equity+incentive |
| Gerard H. Warner III President, CooperVision | $3.6M | 81% equity+incentive |
| Pillar (live disclosure scores) | Score |
|---|---|
| Environmental | 40 |
| Social | 48 |
| Governance | 59 |
| Composite ESG | 49 |
| Filed | 8-K contents | Items |
|---|---|---|
| 2026-09-09 | Earnings Release; Other Events; Exhibits | 2.02,8.01,9.01 |
| 2026-06-04 | Earnings Release; Other Events; Exhibits | 2.02,8.01,9.01 |
| 2026-05-04 | Officer/Director Change | 5.02 |
| 2026-04-08 | Shareholder Vote | 5.07 |
| 2026-03-05 | Results of Operations and Financial Condition; Financial Statements an | 2.02,9.01 |
| 2026-02-04 | Entry into Material Definitive Agreement; Financial Statements and Exh | 1.01,9.01 |
| 2025-12-23 | Entry into Material Definitive Agreement; Departure/Election of Direct | 1.01,5.02,7.01,9.01 |
| 2025-12-12 | Departure/Election of Directors; Appointment of Officers | 5.02 |
Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.
| Data domain | Source | Coverage for this report |
|---|---|---|
| Price & volume | market_db.historical_prices | 52 rows |
| Fundamentals | income_statements_annual | 6 rows · 2020 to 2025 |
| Reported vs consensus | fact/earnings_calendar | 24 rows · 2020-12-03 to 2026-09-09 |
| Analyst estimates | dim/forward_estimates | 3 rows · 2026-10-31 to 2028-10-31 |
| Institutional ownership (13F) | holdings_db.institutional_ownership_summary | 39 rows · 2013 to 2026 |
| Insider transactions (Form 4) | edgar/form4 | 12 rows · 2026-04-01 to 2026-09-16 |
| Proposed sales (Form 144) | edgar/form144 | 1 record |
| Beneficial ownership (13D/G) | edgar/13dg | 4 rows · 2025-11-13 to 2026-05-14 |
| Short-sale volume (FINRA) | edgar/short_volume_daily | 60 rows · 2026-07-23 to 2026-10-15 |
| Dark pool (ATS, tier 1) | edgar/darkpool_weekly | 12 rows · 2026-06-15 to 2026-08-31 |
| ETF & fund holding | etf_holdings_changelog (30d) | 1 record |
| Peer set | stock_peers_dynamic | 8 rows |
| Industry medians | industry_medians | 1 record |
| Congressional trades | congress_db (House + Senate) | 1 record |
| ESG | fact/esg_disclosures | 1 record |
Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.
Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.